| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 04/26/2007 | WO2007046513A2 Benzoylurea compounds and use thereof |
| 04/26/2007 | WO2007046201A1 Metal complex, light-emitting material, and light-emitting device |
| 04/26/2007 | WO2007046075A1 Piperazine derivatives as antimalarial agents |
| 04/26/2007 | WO2007045572A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 04/26/2007 | WO2007045462A2 Novel vanilloid receptor ligands and their use for producing medicaments |
| 04/26/2007 | WO2007017754A3 Androgen modulators |
| 04/26/2007 | WO2007017511A3 Compounds for treating alzheimer's disease |
| 04/26/2007 | WO2007017267A3 Novel compounds |
| 04/26/2007 | WO2006133216A3 4-substituted arylamine derivatives and their use in pharmaceutical compositions |
| 04/26/2007 | WO2006120133A3 Process for coloring keratin fibers comprising metal complexes |
| 04/26/2007 | WO2006099075A3 Certain substituted amides, method of making, and method of use thereof |
| 04/26/2007 | WO2006072775A3 Ionic liquids with a cation comprising a basic moiety |
| 04/26/2007 | US20070093535 Vinyl phenyl derivatives as GLK activators |
| 04/26/2007 | US20070093529 Diacylhydrazine derivatives |
| 04/26/2007 | US20070093522 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide |
| 04/26/2007 | US20070093485 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 04/26/2007 | US20070093481 Benzopyran derivatives substituted with a thioxobenzoxazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containingthem |
| 04/26/2007 | US20070092441 Fluoridation method |
| 04/26/2007 | DE102005050408A1 Neue Vanilloidrezeptor-Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments |
| 04/26/2007 | CA2626438A1 Process for preparation of chiral amlodipine gentisate |
| 04/26/2007 | CA2625918A1 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
| 04/26/2007 | CA2625189A1 Novel vanilloid receptor ligands and their use for producing medicaments |
| 04/26/2007 | CA2625039A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 04/26/2007 | CA2624904A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | CA2623213A1 Piperazine derivatives as antimalarial agents |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776342A1 Process for preparing carboxamide pyridine derivatives used as intermediates in the synthesis of nk-1 receptor antagonists |
| 04/25/2007 | EP1776117A1 Dual nk1/nk3 antagonists against schizophrenia |
| 04/25/2007 | EP1694646B1 Process for the synthesis of pioglitazone hydrogen chloride |
| 04/25/2007 | EP1631533A4 Novel process for stereoselective reduction of beta-ketoesters |
| 04/25/2007 | EP1539147A4 Methods of treating microbial infections in humans and animals |
| 04/25/2007 | EP1049468B1 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers |
| 04/25/2007 | EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors |
| 04/25/2007 | CN1953972A 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 04/25/2007 | CN1951919A Milrinone salt preparation method and its uses |
| 04/25/2007 | CN1951918A Substituted pyridine herbicides |
| 04/25/2007 | CN1951917A Pyridinone derivatives for treatment of atherosclerosis |
| 04/25/2007 | CN1312130C Novel process for the preparation of 2-aminomethylpyridine derivative |
| 04/25/2007 | CN1312119C Process for synthesizing aryl substituted N-aryl amide compounds |
| 04/24/2007 | US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2007 | US7208603 Synthesis method and intermediates of pyridin-2-yl-methylamine |
| 04/24/2007 | US7208557 Functional monomers for molecular recognition and catalysis |
| 04/24/2007 | US7208527 Potassium channel modulators |
| 04/24/2007 | US7208507 Pyridines and uses thereof |
| 04/24/2007 | US7208505 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group |
| 04/24/2007 | US7208497 Substituted piperazines and diazepanes |
| 04/24/2007 | CA2407763C Para-amine substituted phenylamide glucokinase activators |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/24/2007 | CA2075173C Compounds and methods for inhibition of hiv and related viruses |
| 04/19/2007 | WO2007044724A2 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3 |
| 04/19/2007 | WO2007044491A1 N-substituted pyridinone or pyrimidinone compounds useful as soluble epoxide hydrolase inhibitors |
| 04/19/2007 | WO2007044085A2 Heteroaryl compounds and their uses as therapeutic agents |
| 04/19/2007 | WO2007044084A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 04/19/2007 | WO2007043457A1 Triarylcarboxylic acid derivative |
| 04/19/2007 | WO2007042817A1 Naphthalene-disulfonamides useful for the treatment of inflammation |
| 04/19/2007 | WO2007042321A2 Kinase inhibitors |
| 04/19/2007 | WO2007024833B1 Anthranilamides for controlling invertebrate pests |
| 04/19/2007 | WO2007021955A3 NITRO SUBSTITUTED α-OLEFIN SYNTHESIS CATALYSTS |
| 04/19/2007 | WO2007009389A3 Substituted propanamide derivatives, preparation and use thereof |
| 04/19/2007 | WO2005105732A8 Substituted methyl aryl or heteroaryl amide compounds |
| 04/19/2007 | US20070088165 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/19/2007 | US20070088159 Hydroxyalkyl cyclic diamine compounds |
| 04/19/2007 | US20070088058 3-(1(S)(4-chlorobenzyl)-2(S)-((2-hydroxy-2-methyl-1-phenylpropyl)amino)propyl)-benzonitrile; obesity; potentiation; antagonists |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
| 04/19/2007 | CA2623759A1 Pyridopyrimidinone inhibitors of pim 1 and/or pim-3 |
| 04/19/2007 | CA2623500A1 Kinase inhibitors |
| 04/19/2007 | CA2622754A1 N-substituted pyridinone or pyrimidinone compounds useful as soluble epoxide hydrolase inhibitors |
| 04/19/2007 | CA2621038A1 Triarylcarboxylic acid derivative |
| 04/19/2007 | CA2620363A1 Naphthalene-disulfonamides useful for the treatment of inflammation |
| 04/19/2007 | CA2608201A1 Heterocyclic inhibitors of mek and methods of use thereof |
| 04/18/2007 | EP1773797A2 Aromatic compounds |
| 04/18/2007 | EP1773780A2 Amido compounds and their use as pharmaceuticals |
| 04/18/2007 | EP1773778A1 Method for the preparation of crystal forms of torsemide in a pure state |
| 04/18/2007 | EP1773777A1 N-[2-(4-pyridinyl)ethyl]benzamide derivatives as fungicides |
| 04/18/2007 | EP1773776A1 3-pyridinylethylbenzamide derivatives as fungicides |
| 04/18/2007 | EP1773775A1 Six-membered heterocycles useful as serine protease inhibitors |
| 04/18/2007 | EP1773774A2 Heterocyclic acetophenone potentiators of metabotropic glutamate receptors |
| 04/18/2007 | EP1773773A1 Amido compounds and their use as pharmaceuticals |
| 04/18/2007 | EP1773763A1 Lysine based compounds |
| 04/18/2007 | EP1773758A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors |
| 04/18/2007 | EP1773756A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/18/2007 | EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 04/18/2007 | EP1773348A2 Tetrapeptide analogs |
| 04/18/2007 | EP1773337A2 Modulators of nuclear receptors |
| 04/18/2007 | EP1483243B1 Preparation of n1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| 04/18/2007 | EP1425276B1 Heterocyclic carboxamides and their use as fungicides |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1335900B1 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber |
| 04/18/2007 | EP1036066B1 Substituted pyrimidine and pyridine herbicides |
| 04/18/2007 | EP0956865B1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 04/18/2007 | CN1950362A Process for the preparation of tryptase inhibitors |
| 04/18/2007 | CN1950351A 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 04/18/2007 | CN1950339A Process for the production of cyclic diketones |
| 04/18/2007 | CN1950338A Polymer ionic electrolytes |
| 04/18/2007 | CN1950334A Ortho substituted aryl or heteroaryl amide compounds |
| 04/18/2007 | CN1950333A Substituted methyl aryl or heteroaryl amide compounds |
| 04/18/2007 | CN1950332A Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues |
| 04/18/2007 | CN1950319A Process for the production of cyclic diketones |
| 04/18/2007 | CN1948309A Organic eurepium compound based on functional o-phenan throline ligand and its electroluminous device |